MeMed: Chris Hibberd

Israeli infectious disease company MeMed said Chris Hibberd has joined its board of directors. Hibbert is CEO and Executive Chairman of Nucleix. Before that, he was CEO and Cofounder of Astute Medical, which was acquired by BioMérieux. Previously, he was SVP of Corporate Development at Biosite.